CAS 893397-44-9

BMS-688521

CAS : 893397-44-9

BMS-688521

Degré de pureté : ≥98%

Masse moléculaire : 536.37g/mol

Ref: 54-BUP04129

BMS 688521

CAS : 893397-44-9

BMS 688521 is a fluorinated monoclonal antibody that binds to the target protein, which is expressed in inflammatory bowel disease and cancer. It has been shown to stabilize the supramolecular structure of the molecule and inhibit its degradation. The drug targets the microenvironment of the tumor to help deliver chemotherapy drugs to the tumor cells. BMS 688521 is also effective in treating bowel disease by inhibiting inflammation caused by pro-inflammatory cytokines. This drug has been shown to be safe for use in humans in clinical studies with few side effects.

Formule : C₂₆H₁₉Cl₂N₅O₄

Degré de pureté : Min. 95%

Masse moléculaire : 536.37 g/mol

Ref: 3D-TKB39744

BMS-688521

CAS : 893397-44-9

BMS-688521 is an LFA-1/ICAM interaction inhibitor, a small molecule antagonist of LFA-1 with potential anti-inflammatory activity.

Formule : C₂₆H₁₉Cl₂N₅O₄

Degré de pureté : 98.87%

Couleur et forme : Solid

Masse moléculaire : 536.37

Ref: TM-T14676